Barclays Reiterates Equal-Weight Rating on Zoetis Inc. (ZTS)

Market Context

Zoetis Inc. operates in the Healthcare sector. The stock currently trades at $72.47 with a market capitalization of $51.8B. The stock has declined 41.8% over the past 52 weeks.

Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Zoetis Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Zoetis Inc.

Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 01, 2026	Barclays	Equal-Weight	N/A
Jun 30, 2026	TD Cowen	Buy	N/A
Jun 26, 2026	Stifel	Hold	N/A
May 27, 2026	Argus Research	Hold	N/A
May 22, 2026	Stifel	Hold	N/A

Related Tools: Analyst Ratings Dashboard | View ZTS Stock Page